Commonwealth Equity Services’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $31.2M | Sell |
246,685
-11,713
| -5% | -$1.54M | 0.04% | 436 |
|
|
2026
Q1 | $36M | Sell |
258,398
-5,140
| -2% | -$720K | 0.05% | 369 |
|
|
2025
Q4 | $32.3M | Sell |
263,538
-46,058
| -15% | -$5.6M | 0.04% | 405 |
|
|
2025
Q3 | $34.4M | Sell |
309,596
-42,222
| -12% | -$4.8M | 0.04% | 390 |
|
|
2025
Q2 | $39M | Sell |
351,818
-30,930
| -8% | -$3.29M | 0.05% | 358 |
|
|
2025
Q1 | $42.9M | Buy |
382,748
+72,213
| +23% | +$7.45M | 0.06% | 311 |
|
|
2024
Q4 | $28.7M | Sell |
310,535
-13,481
| -4% | -$1.21M | 0.04% | 402 |
|
|
2024
Q3 | $27.2M | Sell |
324,016
-32,726
| -9% | -$2.5M | 0.04% | 422 |
|
|
2024
Q2 | $24.5M | Buy |
356,742
+15,900
| +5% | +$1.06M | 0.04% | 434 |
|
|
2024
Q1 | $25M | Sell |
340,842
-31,610
| -8% | -$2.43M | 0.04% | 422 |
|
|
2023
Q4 | $30.2M | Buy |
372,452
+42,554
| +13% | +$3.31M | 0.06% | 327 |
|
|
2023
Q3 | $24.7M | Sell |
329,898
-16,702
| -5% | -$1.28M | 0.05% | 339 |
|
|
2023
Q2 | $26.7M | Buy |
346,600
+5,266
| +2% | +$420K | 0.05% | 327 |
|
|
2023
Q1 | $28.3K | Buy |
341,334
+19,688
| +6% | +$1.63M | 0.06% | 287 |
|
|
2022
Q4 | $27.6M | Sell |
321,646
-5,643
| -2% | -$447K | 0.07% | 289 |
|
|
2022
Q3 | $20.2M | Buy |
327,289
+15,258
| +5% | +$962K | 0.05% | 333 |
|
|
2022
Q2 | $19.3M | Buy |
312,031
+1,471
| +0.5% | +$91.1K | 0.05% | 358 |
|
|
2022
Q1 | $18.5M | Buy |
310,560
+11,742
| +4% | +$751K | 0.04% | 396 |
|
|
2021
Q4 | $21.7M | Sell |
298,818
-27,050
| -8% | -$1.86M | 0.05% | 348 |
|
|
2021
Q3 | $22.8M | Sell |
325,868
-1,558
| -0.5% | -$109K | 0.06% | 312 |
|
|
2021
Q2 | $22.5M | Sell |
327,426
-8,368
| -2% | -$559K | 0.06% | 322 |
|
|
2021
Q1 | $21.7M | Sell |
335,794
-9,190
| -3% | -$593K | 0.06% | 299 |
|
|
2020
Q4 | $20.1M | Sell |
344,984
-19,370
| -5% | -$1.17M | 0.06% | 295 |
|
|
2020
Q3 | $23M | Sell |
364,354
-8,327
| -2% | -$577K | 0.08% | 243 |
|
|
2020
Q2 | $28.7M | Buy |
372,681
+89,248
| +31% | +$6.84M | 0.11% | 193 |
|
|
2020
Q1 | $21.2M | Buy |
283,433
+70,906
| +33% | +$4.9M | 0.1% | 202 |
|
|
2019
Q4 | $13.8M | Buy |
212,527
+2,405
| +1% | +$157K | 0.05% | 327 |
|
|
2019
Q3 | $13.3M | Buy |
210,122
+2,137
| +1% | +$140K | 0.06% | 322 |
|
|
2019
Q2 | $14.1M | Sell |
207,985
-4,127
| -2% | -$271K | 0.06% | 296 |
|
|
2019
Q1 | $13.8M | Sell |
212,112
-17,210
| -8% | -$1.14M | 0.06% | 295 |
|
|
2018
Q4 | $14.3M | Sell |
229,322
-31,168
| -12% | -$2.18M | 0.08% | 250 |
|
|
2018
Q3 | $20.1M | Sell |
260,490
-27,609
| -10% | -$2.09M | 0.1% | 205 |
|
|
2018
Q2 | $20.4M | Buy |
288,099
+6,296
| +2% | +$445K | 0.11% | 183 |
|
|
2018
Q1 | $21.2M | Sell |
281,803
-11,353
| -4% | -$902K | 0.12% | 170 |
|
|
2017
Q4 | $21M | Sell |
293,156
-24,309
| -8% | -$1.85M | 0.11% | 172 |
|
|
2017
Q3 | $25.7M | Buy |
317,465
+16
| +0% | +$1.22K | 0.15% | 134 |
|
|
2017
Q2 | $22.5M | Buy |
317,449
+3,440
| +1% | +$229K | 0.14% | 140 |
|
|
2017
Q1 | $21.3M | Sell |
314,009
-2,892
| -0.9% | -$203K | 0.14% | 141 |
|
|
2016
Q4 | $22.7M | Sell |
316,901
-35,241
| -10% | -$2.62M | 0.17% | 126 |
|
|
2016
Q3 | $27.9M | Buy |
352,142
+25,723
| +8% | +$2.09M | 0.22% | 93 |
|
|
2016
Q2 | $27.2M | Buy |
326,419
+16,791
| +5% | +$1.49M | 0.23% | 92 |
|
|
2016
Q1 | $28.4M | Buy |
309,628
+43,573
| +16% | +$3.93M | 0.25% | 81 |
|
|
2015
Q4 | $26.9M | Buy |
266,055
+40,158
| +18% | +$4.18M | 0.25% | 82 |
|
|
2015
Q3 | $22.2M | Buy |
225,897
+20,418
| +10% | +$2.27M | 0.23% | 94 |
|
|
2015
Q2 | $24.1M | Buy |
205,479
+8,638
| +4% | +$944K | 0.24% | 89 |
|
|
2015
Q1 | $19.3M | Buy |
196,841
+26,800
| +16% | +$2.72M | 0.2% | 102 |
|
|
2014
Q4 | $16M | Buy |
170,041
+8,566
| +5% | +$886K | 0.18% | 120 |
|
|
2014
Q3 | $17.2M | Buy |
161,475
+33,313
| +26% | +$3.26M | 0.21% | 100 |
|
|
2014
Q2 | $10.6M | Buy |
128,162
+15,471
| +14% | +$1.2M | 0.13% | 151 |
|
|
2014
Q1 | $7.99M | Buy |
112,691
+17,545
| +18% | +$1.38M | 0.11% | 183 |
|
|
2013
Q4 | $7.14M | Buy |
95,146
+19,506
| +26% | +$1.36M | 0.1% | 191 |
|
|
2013
Q3 | $4.75M | Buy |
75,640
+10,143
| +15% | +$606K | 0.08% | 245 |
|
|
2013
Q2 | $3.36M | Buy |
+65,497
| New | +$3.41M | 0.06% | 296 |
|
Other funds holding GILD
Commonwealth Equity Services's GILD Position: Q2 2026 in Review
Commonwealth Equity Services reduced its Gilead Sciences (GILD) stake by 4.5% in Q2 2026, selling an estimated $1.54M and leaving 246,685 shares worth $31.2M. The position accounts for 0.04% of the portfolio, ranked #436.
Commonwealth Equity Services first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $42.9M in Q1 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Commonwealth Equity Services held 246,685 shares of Gilead Sciences worth $31.2M as of Q2 2026.
- Commonwealth Equity Services sold 11,713 Gilead Sciences shares in Q2 2026, an estimated $1.54M.
- Gilead Sciences made up 0.04% of Commonwealth Equity Services's portfolio in Q2 2026, its #436 holding.
- Commonwealth Equity Services first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Commonwealth Equity Services's Gilead Sciences position peaked at $42.9M in Q1 2025.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.